Guidelines & Advice

Hematologic Cancer

These guidelines and other documents provide advice for different types of hematologic cancer: non-Hodgkin lymphoma, leukemia, multiple myeloma, Hodgkin lymphoma, myelodysplastic syndrome (MDS) and myelofibrosis.

CAR T-cell Therapy Enrolment

Displaying Guidelines

53 Items

Stem Cell Transplantation in Primary Systemic Amyloidosis

Document Status: Current
ID: SCT-2
Version: 2

Nov 2019

Stem Cell Transplantation in the Treatment of Acute Lymphoblastic Leukemia: Recommendations

Document Status: In-Review
ID: SCT 6

Feb 2016

Summary of Recommendations for Primary Care Management after Stem Cell Transplant

Document Status: Current
Version: 2

Mar 2022

Systemic Therapy in Acute Lymphoblastic Leukemia

Document Status: Archived
ID: 12-16

Jun 2016

Systemic Treatment of Acute Myeloid Leukemia (AML)

Document Status: In-Review
ID: 12-9

Jan 2016

T-Cell Engaging Antibodies: Management of Cytokine Release Syndrome (CRS) and Immune Effector-Associated Neurotoxicity Syndrome (ICANS)

Document Status: Current

Updated

Mar 2025

Thalidomide in Multiple Myeloma

Document Status: Archived
ID: 6-21

Jan 2010

The Management of Malignant Thrombocytosis in Philadelphia Chromosome-Negative Myeloproliferative Disease

Document Status: Archived
ID: 6-9

Jan 2008

The Prognostic Value of the DNMT3A Biomarker in Cytogenetically Normal Patients with Acute Myeloid Leukemia

Document Status: Archived
ID: MOAC 1

Nov 2013

The Prophylactic Use of Filgrastim in Patients with Hematological Malignancies

Document Status: Archived
ID: CED 14-1

Sep 2009

The Role of Bisphosphonates in the Management of Skeletal Complications for Patients with Multiple Myeloma

Document Status: Archived
ID: 6-4

Oct 2012

The Use of Chemotherapy and Growth Factors in Older Patients with Newly Diagnosed, Advanced Stage, Aggressive Histology Non-Hodgkin's Lymphoma

Document Status: Education and Information
ID: 6-7 Version 2
Version: 2

Jun 2013